Trihexyphenidyl is an oral anticholinergic agent used predominantly in the symptomatic therapy of Parkinson disease and movement disorders. Trihexyphenidyl has not been associated with serum enzyme elevations during treatment, but has been implicated in rare cases of acute liver injury. It is grouped under the following drug class(es): Anticholinergics. Its therapeutic use is listed as antiparkinsonian agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Benzhexol, Triesifenidile, Pacitane and Pargitan. Its PubChem CID is 5572.
Trihexyphenidyl
| CAS No | 144-11-6 |
|---|---|
| Molecular Formula | C20H31NO |
| Molecular Weight | 301.5 g/mol |
| Synonyms | 1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Trihexyphenidyl is an oral anticholinergic agent used predominantly in the symptomatic therapy of Parkinson disease and movement disorders. Trihexyphenidyl has not been associated with serum enzyme elevations during treatment, but has been implicated in rare cases of acute liver injury.
The listed CAS number is 144-11-6.
The listed molecular formula is C20H31NO.
The listed molecular weight is 301.5 g/mol.
1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol.
The source lists Benzhexol, Triesifenidile, Pacitane and Pargitan.